N-Heterocycle C−H Activation by Rh(I)/PCy3
A R T I C L E S
and N,N′-dimethyl-ethane-1,2-diamine (87 mg, 0.98 mmol) were
combined in 1,4-dioxane (5 mL), and this mixture was stirred until the
CuI completely dissolved. The resulting solution was added to a glass-
walled vessel equipped with a vacuum stopcock containing (2-bromo-
benzyl)-methyl-amine56 (983 mg, 4.91 mmol), 15N-benzamide (600 mg,
4.91 mmol), K2CO3 (1.36 g, 9.83 mmol), and a magnetic stirbar. The
reaction vessel was sealed and heated at 110 °C for 5.5 h until TLC
(5% Et3N in EtOAc) indicated complete consumption of the aryl
bromide. The crude reaction mixture was filtered through a pad of silica
eluting with CH2Cl2 containing 5% of a mixture of 10% NH4OH in
MeOH to give a yellow oil. This material was suspended in 5 mL of
water, and then 10 mL of concentrated HCl was added dropwise. The
resulting solution was washed (3 × 2 mL of Et2O) and then resealed
into the original reaction vessel and heated at 105 °C for 24 h. After
being cooled to 0 °C, the reaction solution was basified by dropwise
addition of NH4OH and extracted with Et2O (3 × 40 mL). The
combined ethereal phases were washed with brine, dried over MgSO4,
and concentrated under vacuum to give a yellow oil. After silica gel
chromatography (50% f 95% EtOAc in hexanes with 5% Et3N), 4
(324 mg, 48%) was obtained as a yellow oil. Its spectroscopic properties
were consistent with data reported for 2-methylaminomethyl-phenyl-
amine.57 1H NMR (500 MHz, C6D6): 7.11 (t, 1H, J ) 7.6 Hz, Ar-H),
6.96 (d, 1H, J ) 7.3 Hz, Ar-H), 6.73 (t, 1H, J ) 7.4 Hz, Ar-H), 6.43
(d, 1H, J ) 7.8 Hz, Ar-H), 4.43 (bd, 2H, JN-H ) 79.0 Hz, 15NH2),
3.47 (s, 2H, CH2), 2.01 (s, 3H, CH3), 0.29 (bs, 1H, NH). 13C NMR
(125 MHz, C6D6): 148.3 (d, JN-C ) 10.4 Hz, C-15N), 130.5, 129.0,
124.4 (d, JN-C ) 2.0 Hz), 117.8, 116.0 (d, JN-C ) 1.8 Hz), 56.1 (CH2),
36.1 (CH3). 15N {1H} NMR (40 MHz, C6D6): 55.8.
collected for 1, except that the 1H NMR signal at δ 6.6 ppm was absent,
1
as expected. IR: 2240 cm-1 (C-D). H NMR (400 MHz, C6D6): δ
7.51 (d, 1H, J ) 7.8 Hz, Ar-H), 7.08 (t, 1H, J ) 8.3 Hz, Ar-H), 6.89
(t, 1H, J ) 7.4 Hz, Ar-H), 6.56 (d, 1H, J ) 7.5 Hz, Ar-H), 3.74 (s,
2H, CH2), 1.79 (s, 3H, CH3). 13C NMR (125 MHz, DCO2D): δ 147.4
(t, JD-C ) 31 Hz, C2), 127.4, 126.9, 125.8, 124.8, 115.0, 114.9, 46.6,
39.8. 2H NMR (61 MHz, C6H6): δ 6.6. MS (ESI); m/z (%): 147 [1H-
M+ + H] (0.92), 148 [M+ + H] (100), 149 [D-M+ + H] (10.5).
2
Calcd: 99% H.
General Procedure for Observing Isotopically Labeled Rh-
Complexes. To an NMR tube was added a solution containing labeled-1
(3.8 mg, 25 µmol), [(coe)2RhCl]2 (9.0 mg, 13 µmol), and PCy3 (14.0
mg, 50 µmol) in d8-THF (0.5 mL). The tube was flame-sealed under
vacuum, and then heated between 45 and 75 °C for 1-24 h to observe
varying ratios of free 1, 3, and 2. The distinctive resonances corre-
sponding to the various complexes are reported as part of these mixtures.
From 15N1-1: trans-(3-Methyl-1,2,3,4-tetrahydro-1-15NH-quinazo-
lin-2-ylidene)(PCy3)2RhCl (15N1-2, 2dir from Crossover Experiment).
Its spectroscopic properties were consistent with data collected for 2.
1H NMR (400 MHz, d8-THF): δ 7.98 (d, 1H, JN-H ) 94.0 Hz, N-H).
This compound was not sufficiently soluble to obtain an 15N NMR
spectrum.
trans-N1-(3-Methyl-3,4-dihydro-1-15N-quinazoline)(PCy3)2RhCl
(15N1-3). Its spectroscopic properties were consistent with data collected
1
for 3. H NMR (400 MHz, d8-THF): δ 7.61 (d, 1H, JN-H ) 7.2 Hz,
C2-H). 31P NMR (160 MHz, d8-THF): δ 22.1 (d, JRh-P ) 143 Hz,
JN-P ) 3.0 Hz). This compound was not sufficiently soluble to obtain
an 15N NMR spectrum.
3-Methyl-3,4-dihydro-1-15N-quinazoline (15N1-1). The reaction was
performed as described in the general procedure using 4 (100 mg, 0.73
mmol). The white solid obtained after crystallization (55 mg, 51%)
exhibited spectroscopic properties consistent with data collected for 1.
1H NMR (400 MHz, CDCl3): δ 7.14 (t, 1H, J ) 7.6 Hz, Ar-H), 7.04
(d, 1H, J ) 7.9 Hz, Ar-H), 6.98 (t, 1H, J ) 7.4 Hz, Ar-H), 6.96 (d,
1H, JN-H ) 13.1 Hz, C2-H), 6.83 (d, 1H, J ) 7.5 Hz, Ar-H), 4.49
(s, 2H, CH2), 2.88 (s, 3H, CH3). 13C NMR (100 MHz, CDCl3): δ 150.3
(d, JN-C ) 3.0 Hz, C2), 141.5, 128.3 (d, JN-C ) 3.0 Hz), 125.5, 124.6,
124.5 (d, JN-C ) 8.9 Hz, C9), 120.0, 48.9, 39.7. 15N NMR (40 MHz,
CDCl3): δ 203.4 (d, JH-N ) 13.2 Hz). MS (EI); m/z (%): 145 [14N-
M+ - H] (2.0), 146 [(14N-M+) + (15N-M+ - H)] (100), 147 [(15N-M+)
+ (15N,D-M+ - H)] (45.6). Calcd: 99% 15N by comparison to the
fragmentation pattern of 1.
From 15N1,13C2-1: trans-(3-Methyl-1,2,3,4-tetrahydro-1-15NH,2-
13C-quinazolin-2-ylidene)(PCy3)2RhCl (15N1,13C2-2). Its spectroscopic
properties were consistent with data collected for 15N1-2. 1H NMR (500
MHz, d8-THF): δ 7.99 (dd, 1H, JN-H ) 94.5 Hz, JC-H ) 3.9 Hz, N-H),
4.09 (d, 3H, JC-H ) 4.0 Hz, CH3). 13C NMR (125 MHz, d8-THF): δ
216.4 (dtd, JRh-C ) 54.4 Hz, JP-C ) 12.1 Hz, JN-C ) 2.0 Hz, C2).
trans-N1-(3-Methyl-3,4-dihydro-1-15N,2-13C-quinazoline)(PCy3)2-
RhCl (15N1,13C2-3). Its spectroscopic properties were consistent with
1
data collected for 15N1-3. H NMR (500 MHz, d8-THF): δ 7.60 (dd,
1H, JC-H ) 193 Hz, JN-H ) 7.4 Hz, C2-H), 2.97 (d, 3H, JC-H ) 4.1
Hz, CH3). 13C NMR (125 MHz, d8-THF): δ 155.2 (d, JN-C ) 10.5
Hz, C2).
From C2-D-1: trans-(3-Methyl-1,2,3,4-tetrahydro-1H,2-2H-quinazo-
lin-2-ylidene)-(PCy3)2RhCl (C2-D-2, 2dirD from Crossover Experi-
ment). Its spectroscopic properties were consistent with data collected
for 2, except that the 1H NMR signal at δ 8.0 ppm (N-H) was greatly
diminished, as expected. IR: 2543 cm-1 (N-D).
trans-N1-(3-Methyl-3,4-dihydro-2-2H-quinazoline)(PCy3)2RhCl (C2-
D-3). Its spectroscopic properties were consistent with data collected
for 3, except that the 1H NMR signal at δ 7.6 ppm (C2-H) was absent,
as expected.
3-Methyl-3,4-dihydro-1-15N,2-13C-quinazoline (15N1,13C2-1). The
reaction was performed as described in the general procedure using 4
(75 mg, 0.55 mmol) with 13C-formic acid (250 mg, 5.3 mmol). The
white solid obtained after crystallization (27 mg, 33%) exhibited
1
spectroscopic properties consistent with data collected for 15N1-1. H
NMR (400 MHz, C6D6): δ 7.49 (d, 1H, J ) 7.8 Hz, Ar-H), 7.08 (t,
1H, J ) 7.7 Hz, Ar-H), 6.90 (t, 1H, J ) 7.4 Hz, Ar-H), 6.59 (dd,
1H, JC-H ) 190 Hz, JN-H ) 13.4 Hz, C2-H), 6.57 (d, 1H, J ) 7.6
Hz, Ar-H), 3.75 (s, 2H, CH2), 1.81 (d, 3H, JC-H ) 4.0 Hz, CH3). 13
C
Procedure for Deuterium Tracer Experiment. In a N2 atmosphere
glovebox, C2-D-1 (3.8 mg, 26 µmol), [(coe)2RhCl]2 (8.9 mg, 12 µmol),
PCy3 (14.4 mg, 51 µmol), and 2,6-dimethoxytoluene (1.1 mg, 7 µmol)
were combined in d8-THF (0.5 mL). This mixture was flame-sealed
into a medium-walled NMR tube and then heated at 70 °C overnight.
After the mixture was cooled to room temperature, analysis of the
reaction mixture by 1H NMR indicated 80% yield of 3 with 88%
incorporation of deuterium at the N1-H position.
Procedure for Double Labeling Crossover Experiment (with C2-
D-1 and 15N1-1). In a N2 atmosphere glovebox, C2-D-1 (0.9 mg, 6
µmol), 15N1-1 (0.9 mg, 6 µmol), [(coe)2RhCl]2 (4.5 mg, 6 µmol), PCy3
(8.8 mg, 31 µmol), and 2,6-dimethoxytoluene (1.9 mg, 12 µmol) were
combined in d8-THF (0.5 mL). This mixture was flame-sealed into a
medium-walled NMR tube that was then heated at 45 °C for 1 d.
Periodically, the reaction tube was removed from its heating bath, cooled
to room temperature, and a one-pulse 1H NMR spectrum was acquired
NMR (100 MHz, THF) (only partial data given): δ 150.1 (d, JN-C
)
3.0 Hz, C2). MS (EI); m/z (%): 146 [singly labeled-M+ - H] (3.2),
147 [(singly labeled-M+) + (15N,13C-M+ - H)] (100), 148 [(15N,13C-
M+) + (15N,13C,D-M+ - H)] (44.8). Calcd: 96% 15N,13C by comparison
to the fragmentation pattern of 1.
3-Methyl-3,4-dihydro-2-2H-quinazoline (C2-D-1). The reaction was
performed as described in the general procedure using 2-methylami-
nomethyl-phenyl-14N-amine58 (125 mg, 0.92 mmol) with D2-formic acid
(500 mg, 10.4 mmol). The white solid obtained after crystallization
(48 mg, 35%) exhibited spectroscopic properties consistent with data
(56) Analytical data and a synthetic protocol have been reported for (2-bromo-
benzyl)-methyl-amine: Philippe, N.; Denivet, F.; Vasse, J.-L.; Santos, J.
S. O.; Levacher, V.; Dupas, G. Tetrahedron 2003, 59, 8049.
(57) Coyne, W. E.; Cusic, J. W. J. Med. Chem. 1968, 11, 1208.
(58) Prepared according to the procedure for 4.
9
J. AM. CHEM. SOC. VOL. 128, NO. 7, 2006 2461